Urban Novak

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53

Tobias Grob, Urban Novak, Carine Maisse et al. · Cell Death and Differentiation · 2001 · 334 citations · Full text

Transcriptional Regulation, Signal Transduction, Signaling Pathway +9

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial

Andrew Davies, Thomas Cummin, Sharon Barrans et al. · The Lancet Oncology · 2019 · 260 citations · Full text

The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas

Urban Novak, Andrea Rinaldi, Ivo Kwee et al. · Blood · 2009 · 240 citations · Full text

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

Masumichi Saito, Urban Novak, Erich Piovan et al. · Proceedings of the National Academy of Sciences · 2009 · 192 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Malignant Blood Disorder +11